Screener
Ocular Therapeutix OCUL Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $8,026 | $4,154 |
| Accrued expenses and other current liabilities | 36,487 | 43,835 |
| Operating lease liabilities | 3,170 | 2,817 |
| Total current liabilities | 47,683 | 50,806 |
| Other liabilities: | ||
| Operating lease liabilities, net of current portion | 4,230 | 2,815 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's accrued expenses?
- Ocular Therapeutix (OCUL) reported accrued expenses of $36.49M in Q1 2026.
- How has Ocular Therapeutix's accrued expenses changed year-over-year?
- Ocular Therapeutix's accrued expenses increased by 17.4% year-over-year, from $31.08M to $36.49M.
- What is the long-term trend for Ocular Therapeutix's accrued expenses?
- Over 5 years (2020 to 2025), Ocular Therapeutix's accrued expenses has grown at a 25.1% compound annual growth rate (CAGR), from $14.31M to $43.84M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Ocular Therapeutix's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude